Pamrevlumab

From Wikipedia, the free encyclopedia

Type?
SourceHuman
TargetCTGF
Other namesFG-3019
Pamrevlumab
Monoclonal antibody
Type?
SourceHuman
TargetCTGF
Clinical data
Other namesFG-3019
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6492H10018N1718O2086S48
Molar mass147050.38 g·mol−1

Pamrevlumab (INN;[1] development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.[2]

This drug was developed by FibroGen.[3]

Related Articles

Wikiwand AI